Robert H. Resis provides useful strategies for patent owners in inter partes review proceedings in biotechnology and pharmaceutical patents in Part I of his two-part series in BNA’s Patent, Trademark and Copryight Journal.
Please click here to read, “A Patent Owner’s Guide to Handling IPRs in the Higher-Survival Patent Arena of Biotech and Pharmaceuticals.” A subscription is required.
Please click here for a PDF version.
Posted: April 8, 2016